1761 - 1770 of 8823 Results
Title
Year
-
OPENTitle: Screening non-MAPT genes of the Chr17q21 H1 haplotype in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 78Issue #:Start Page: 138End Page: 144Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.07.022Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7686230Citation Count: 17
-
OPENTitle: A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 144End Page: 150Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.029Best OA location URL: http://www.prd-journal.com/article/S1353802020308221/pdfCitation Count: 22
-
OPENTitle: Co-Existence of tau and α-synuclein pathology in fetal graft tissue at autopsy: A case reportJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 71Issue #:Start Page: 36End Page: 39Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.013Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7085430Citation Count: 14
-
OPENTitle: The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotensionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 75Issue #:Start Page: 97End Page: 104Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.04.011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7415666Citation Count: 62
-
OPENTitle: Genetic characterization of Parkinson's disease patients in Ecuador and ColombiaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 75Issue #:Start Page: 27End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.005Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10236935/pdf/nihms-1900454.pdfCitation Count: 8
-
OPENTitle: 6 Association Between American Football Play and Parkinson's Disease: Analysis of the Fox Insight Data SetJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 29Issue #: s1Start Page: 415End Page: 416Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617723005507Citation Count: 0
-
OPENTitle: Prediction of dyskinesia in Parkinson’s disease patients using machine learning algorithmsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 22426End Page: 22426Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-49617-wBest OA location URL: https://www.nature.com/articles/s41598-023-49617-w.pdfCitation Count: 8
-
OPENTitle: α-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: an in vitro proof of concept studyJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 5Issue #: 6Start Page: fcad285End Page: fcad285Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcad285Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcad285/52454987/fcad285.pdfCitation Count: 15
- Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregation2023OPENTitle: Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregationJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 46Start Page: eadi8716End Page: eadi8716Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adi8716Best OA location URL: https://doi.org/10.1126/sciadv.adi8716Citation Count: 201
-
OPENTitle: Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structuresJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 48Start Page: eadk6191End Page: eadk6191Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adk6191Best OA location URL: https://doi.org/10.1126/sciadv.adk6191Citation Count: 43